Sex cord-stromal neoplasms account for ~10% of all ovarian neoplasms. They are composed of various cell types derived from gonadal stroma and sex cords. They account for most of the hormonally active ovarian tumors. Granulosa cell tumors and Sertoli-Leydig cell tumors are the most common. Unlike patients with common epithelial tumors, in which 75% are considered to be at stage III or IV at diagnosis, patients with these tumors are at stage I at diagnosis 70% of the time. Also unlike common epithelial tumors, sex cord-stromal tumors often have more specific symptoms.
Alpha-inhibin
has become a most useful immunohistochemical marker of gonadal ovarian sex cord-stromal tumors (SCST), regardless if the tumors are primary, recurrent, or metastatic. PMID: 12502966
Calretinin
has been recently recognized as a more
sensitive, but less specific marker for SCSTs and it may be used
to recognize an inhibin-negative SCST.
PMID: 12502966
a more
sensitive but less specific marker than alpha-inhibin for
ovarian sex cord-stromal neoplasms: an immunohistochemical study
of 215 cases indicated that calretinin is particularly
useful in the diagnosis of sex cord-stromal and fibrous
neoplasms that are inhibin negative.
PMID: 12409724